Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample

被引:189
作者
Winstock, Adam R. [1 ,2 ]
Barratt, Monica J. [3 ]
机构
[1] Kings Coll London, South London & Maudsley NHS Trust, London, England
[2] Global Drug Survey, London, England
[3] Curtin Univ, Natl Drug Res Inst, Melbourne, Vic, Australia
关键词
Synthetic cannabinoids; Cannabis; Epidemiology; Online survey; 5-YEAR TRENDS; DRUG-USE; SPICE; METABOLITES; MEPHEDRONE; JWH-018;
D O I
10.1016/j.drugalcdep.2012.12.011
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The last decade has seen the appearance of myriad novel psychoactive substances with diverse effect profiles. Synthetic cannabinoids are among the most recently identified but least researched of these substances. Methods: An anonymous online survey was conducted in 2011 using a quantitative structured research tool. Missing data (median 2%) were treated by available-case analysis. Results: Of 14,966 participants, 2513 (17%) reported use of synthetic cannabis. Of these, 980 (41% of 2417) reported its use in the last 12 months. Almost all recent synthetic cannabis users (99% of 975) reported ever use of natural cannabis. Synthetic cannabis reportedly had both a shorter duration of action (z = 17.82, p < .001) and quicker time to peak onset of effect (z = -9.44, p < .001) than natural cannabis. Natural cannabis was preferred to synthetic cannabis by 93% of users, with natural cannabis rated as having greater pleasurable effects when high (t(930) = -37.1, p < .001, d = -1.22) and being more able to function after use (t(884) = -13.3, p < .001, d = -0.45). Synthetic cannabis was associated with more negative effects (t(859) = 18.7, p < .001, d = 0.64), hangover effects (t(854) = 6.45, p < .001, d = 0.22) and greater paranoia (t(889) = 7.91, p < .001, d = 0.27). Conclusions: Users report a strong preference for natural over synthetic cannabis. The latter has a less desirable effect profile. Further research is required to determine longer term consequences of use and comparative dependence potential. (C) 2013 Published by Elsevier Ireland Ltd.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 42 条
[1]  
Advisory Council on the Misuse of Drugs, 2009, CONS MAJ CANN AG
[2]   Patterns of synthetic cannabinoid use in Australia [J].
Barratt, Monica J. ;
Cakic, Vince ;
Lenton, Simon .
DRUG AND ALCOHOL REVIEW, 2013, 32 (02) :141-146
[3]   New Zealand bans synthetic cannabinoids [J].
Brown, Karen .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
[4]   Synthetic Cannabinoid Use: Recognition and Management [J].
Castellanos, Daniel ;
Thornton, Gabriel .
JOURNAL OF PSYCHIATRIC PRACTICE, 2012, 18 (02) :86-93
[5]   Synthetic Cannabinoid Use: A Case Series of Adolescents [J].
Castellanos, Daniel ;
Singh, Simar ;
Thornton, Gabriel ;
Avila, Maria ;
Moreno, Ana .
JOURNAL OF ADOLESCENT HEALTH, 2011, 49 (04) :347-349
[6]   The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice' [J].
Dargan, Paul I. ;
Hudson, Simon ;
Ramsey, John ;
Wood, David M. .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2011, 22 (04) :274-277
[7]   The Secret "Spice'': An Undetectable Toxic Cause of Seizure [J].
de Havenon, Adam ;
Chin, Brian ;
Thomas, Karen C. ;
Afra, Pegah .
NEUROHOSPITALIST, 2011, 1 (04) :182-186
[8]   LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine - An Australian perspective [J].
de Jager, Andrew D. ;
Warner, Janet V. ;
Henman, Michael ;
Ferguson, Wendy ;
Hall, Ashley .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 897 :22-31
[9]  
European Monitoring Centre for Drugs and Drug Addiction, 2010, 2010 ANN REP STAT DR
[10]  
Evans-Brown M., 2011, BRIT MED J, V342, P501